Sign in

CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$16,043,610
in 4 filings, $16.0M under 10b5-1 plans

Net −$16,043,610. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Savitz Ryan −$11.2M EVP, CFO & CBO sold 100% of stake
  2. Randhawa Simrat −$2.5M EVP, Head of R&D sold 85% of stake
  3. CARR EDWARD −$2.0M CHIEF ACCOUNTING OFFICER sold 100% of stake
  4. Read Simon −$327K Director sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2023-09-11 Fairmount Funds Management LLC Director Grant or award · Stock Option (Right to Buy) +6,500 6,500
2023-09-11 Violin Jonathan Director Grant or award · Stock Option (Right to Buy) +6,500 6,500
2023-09-11 Lawton Alison Frances Director Grant or award · Stock Option (Right to Buy) +6,500 6,500
2023-09-11 Soteropoulos Paula Director Grant or award · Stock Option (Right to Buy) +6,500 6,500
2023-09-11 McGeorge Anne Director Grant or award · Stock Option (Right to Buy) +6,500 6,500
2023-09-11 MOULDER LEON O JR Director Grant or award · Stock Option (Right to Buy) +6,500 6,500
2023-02-08 Third Rock Ventures IV, L.P. 10% owner Sale −1,500,000 $0.82 $1.2M 3,058,204
2023-02-07 Third Rock Ventures IV, L.P. 10% owner Sale −2,200,000 $0.83 $1.8M 4,558,204
2022-11-30 Beetham Thomas W. See Remarks Grant or award +3,000 $0.94 $3K 19,897
2022-11-30 Mahoney Stephen F. See Remarks Grant or award +3,000 $0.94 $3K 17,264
2022-11-30 Deardorf Caren Chief Commercial Officer Grant or award +3,000 $0.94 $3K 19,762
2022-11-30 GARDNER JASON See Remarks Grant or award +3,000 $0.94 $3K 292,872
2022-11-30 Stants Kristen Chief People Officer Grant or award +3,000 $0.94 $3K 20,264
2022-08-15 VASCONCELLES MICHAEL Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2022-08-01 Olson Lisa See Remarks Grant or award · Stock Option (Right to Buy) +100,000 100,000
2022-08-01 Beetham Thomas W. See Remarks Grant or award · Stock Option (Right to Buy) +75,000 75,000
2022-08-01 Humphrey Jeffrey Chief Medical Officer Grant or award · Stock Option (Right to Buy) +75,000 75,000
2022-08-01 GARDNER JASON See Remarks Grant or award · Stock Option (Right to Buy) +187,500 187,500
2022-08-01 Nichols David Wayne Chief Technical Officer Grant or award · Stock Option (Right to Buy) +75,000 75,000
2022-08-01 Mahoney Stephen F. See Remarks Grant or award · Stock Option (Right to Buy) +130,000 130,000

Page 13 of 24 · 470 trades